Enchannel

A global innovation platform specializing in electrophysiology, offering advanced 3D mapping combined with PFA ablation for atrial fibrillation treatment.

Add To Watchlist
General Information
Company Name
Enchannel
Founded Year
2020
Location (Offices)
+3
Founders / Decision Makers
Number of Employees
11-50
Industries
Biotechnology, Health and Wellness
Funding Stage
Series A
Social Media

Enchannel - Company Profile

Enchannel is a biotechnology startup, founded in 2020, that has recently attracted significant attention from investors. Positioned as a global innovation platform specializing in electrophysiology, Enchannel offers advanced 3D mapping combined with PFA ablation for atrial fibrillation treatment. The company's slogan succinctly communicates its focus on providing advanced solutions for atrial fibrillation treatment. In August 2023, Enchannel secured a noteworthy CNY200.00M Series A investment from Lilly Asia Ventures and Longpan Investment. This substantial investment demonstrates the confidence that prominent investors have in the potential of Enchannel's innovative approach to addressing critical medical needs in the sphere of electrophysiology.

Taxonomy: Electrophysiology, Atrial Fibrillation, 3D Mapping, PFA Ablation, Medical Technology, Innovation, Cardiology, Global Platform

Funding Rounds & Investors of Enchannel (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A CNY200.00M 2
Lilly Asia Ventures, investor in Enchannel's Series A round
Longpan Investment 		01 Aug 2023

Latest News of Enchannel

View All

No recent news or press coverage available for Enchannel.

Similar Companies to Enchannel

View All

No funding or investment information available for Enchannel at this time.

Circle Decoration Circle Decoration

Want to dive deeper into Enchannel? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now